← Back to Search

Endoscope

aScope™ Duodeno endoscope and aBox™ Duodeno for Endoscopic Retrograde Cholangiopancreatography

N/A
Waitlist Available
Research Sponsored by Ambu A/S
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 30 (+3) post-procedure
Awards & highlights
No Placebo-Only Group

Summary

This study will assess how the aScope™ Duodeno endoscope performs in procedures that treat problems of the bile and pancreatic ducts.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 30 (+3) post-procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 30 (+3) post-procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To evaluate the ERCP procedural success rates with the aScope™ Duodeno endoscope when completing the ERCP procedure for the intended indication(s).
Secondary study objectives
To establish comprehensive performance attributes of aScope™ Duodeno endoscope through its use by multiple endoscopists in conducting various ERCP procedures.
To evaluate physician satisfaction with the aScope™ Duodeno endoscope.
To evaluate rate of conversion to a reusable endoscope, other endoscope or an open procedure from the aScope™ Duodeno endoscope during the ERCP procedure.
+2 more
Other study objectives
To evaluate safety of the aScope™ Duodeno endoscope in ERCP.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: aScope™ Duodeno endoscope and aBox™ DuodenoExperimental Treatment1 Intervention
Eligible subjects who are undergoing non-emergent, clinically indicated ERCP using aScope™ Duodeno endoscope and aBox™ Duodeno.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
aScope™ Duodeno endoscope and aBox™ Duodeno
2021
N/A
~250

Find a Location

Who is running the clinical trial?

Prelude DynamicsUNKNOWN
Infinite Clinical SolutionsUNKNOWN
Ambu A/SLead Sponsor
23 Previous Clinical Trials
5,491 Total Patients Enrolled
~53 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top